CHIA TAI ENTERPRISES INTERNATIONAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7 HKD | +2.94% |
|
+4.48% | -26.32% |
| Feb. 23 | Chia Tai Enterprises International Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 23 | Chia Tai Enterprises International Limited Announces Board Changes | CI |
| Sales 2021 | 142M 1.11B | Sales 2022 | 159M 1.25B | Capitalization | 20.34M 159M |
|---|---|---|---|---|---|
| Net income 2021 | 19M 149M | Net income 2022 | -6M -46.97M | EV / Sales 2021 | 0.38 x |
| Net Debt 2021 | 11.52M 90.17M | Net Debt 2022 | 18.24M 143M | EV / Sales 2022 | 0.24 x |
| P/E ratio 2021 |
2.29
x | P/E ratio 2022 |
-3.21
x | Employees | 1,000 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 26.74% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.94% | ||
| 1 week | +4.48% | ||
| Current month | -16.67% | ||
| 1 month | -13.58% | ||
| 3 months | -18.60% | ||
| 6 months | -45.74% | ||
| Current year | -26.32% |
1 week
0.65
0.77
1 month
0.650.85
Current year
0.650.99
1 year
0.652.30
3 years
0.656.98
5 years
0.656.98
10 years
0.658.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 81 | 14-09-14 | |
| Director/Board Member | 78 | 88-02-11 | |
Wing Yuen Lau
SEC | Corporate Secretary | 58 | 22-08-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 78 | 88-02-11 | |
| Chairman | 59 | 14-09-14 | |
Ming Tung Ko
BRD | Director/Board Member | 63 | 14-09-14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 0.7 | +2.94% | 56 560 |
| 24-04-24 | 0.68 | -1.45% | 201,000 |
| 24-04-23 | 0.69 | -1.43% | 82,500 |
| 24-04-22 | 0.7 | +6.06% | 47,500 |
| 24-04-19 | 0.66 | -1.49% | 47,000 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT
More quotes
Chia Tai Enterprises International Limited is an investment holding company principally engaged in the manufacture and sale of chlortetracycline. The Company operates its business through two segments. The Biochemical segment is engaged in the manufacture and sale of chlortetracycline products. The Industrial segment is engaged in the trading of machinery and the manufacture and sale of automotive parts.
Sector
Agricultural Chemicals
Calendar
2024-05-07
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -26.32% | 20.9M | |
| +13.98% | 38.28B | |
| -.--% | 11.12B | |
| -8.45% | 7.29B | |
| +6.91% | 6.83B | |
| -5.49% | 5.61B | |
| -11.04% | 5.52B | |
| +30.13% | 5.13B | |
| -13.89% | 4.49B | |
| +17.77% | 4.33B |
- Stock Market
- Equities
- 3839 Stock
